NCT03148808View on ClinicalTrials.gov

Natural Vascular Scaffold (NVS) Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

October 29, 2018

Study Completion Date

October 29, 2018

Conditions
Peripheral Arterial DiseasePeripheral Vascular DiseasesCatheterization, Peripheral
Interventions
COMBINATION_PRODUCT

NVS Therapy

Combination Product: NVS Therapy which includes NVS Injection (investigational product) and the following investigational devices: NVS Delivery Catheter, NVS Light Fiber, and NVS Light Source.

Trial Locations (3)

19096

Lankenau Institute for Medical Research, Wynnewood

37660

Wellmont CVA Heart Institute, Kingsport

43214

OhioHealth Research Institute, Columbus

Sponsors

Lead Sponsor

Alucent Biomedical
All Listed Sponsors
lead

Alucent Biomedical

INDUSTRY

NCT03148808 - Natural Vascular Scaffold (NVS) Therapy | Biotech Hunter | Biotech Hunter